Skip to main content
Erschienen in: International Journal of Colorectal Disease 5/2022

11.04.2022 | Original Article

Pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of 26 studies

Erschienen in: International Journal of Colorectal Disease | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Transanal total mesorectal excision (TaTME) has the potential advantages for patients with low rectal cancer. The objective of this meta-analysis was to identify the pathologic outcomes between the TaTME and laparoscopic total mesorectal excision (LaTME) in rectal cancer.

Methods

The literature searches were conducted in PubMed, Cochrane Library, and EMBASE with English language restriction. The primary endpoint was circumferential margin (CRM), and the secondary endpoints were distal resection margin (DRM), mesorectal excision quality, and harvested lymph nodes.

Results

Our research identified 1090 articles, and 26 studies met the inclusion criteria for the meta-analysis. The positive CRM was lower in the TaTME than the LaTME (OR = 0.72; 95% CI = 0.53, 0.98; P = 0.04). There was no significant difference in the positive CRM between the TaTME and LaTME published after 2016 (OR = 0.80; 95% CI = 0.57, 1.12; P = 0.19), prospective study (OR = 2.70; 95% CI = 0.51, 14.24; P = 0.24), respective study (OR = 0.76; 95% CI = 0.55, 1.04; P = 0.09), BMI > 26 (OR = 1.00; 95% CI = 0.63, 1.58; P = 0.98), or sample size > 100 (OR = 0.84; 95% CI = 0.57, 1.23; P = 0.38). In addition, there was no significant difference observed between the TaTME and LaTME in terms of DRM, mesorectum incompleteness, and harvested lymph nodes.

Conclusions

The TaTME is associated with lower positive CRM compared to the LaTME and similar pathologic outcomes including DRM, harvested lymph node, and mesorectal excision quality.
Literatur
1.
Zurück zum Zitat MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341(8843):457–460CrossRef MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341(8843):457–460CrossRef
2.
Zurück zum Zitat van Gijn W, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6):575–582CrossRef van Gijn W, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6):575–582CrossRef
3.
Zurück zum Zitat Roodbeen SX, Penna M, Mackenzie H et al (2019) Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes. Surg Endosc 33(8):2459–2467CrossRef Roodbeen SX, Penna M, Mackenzie H et al (2019) Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes. Surg Endosc 33(8):2459–2467CrossRef
4.
Zurück zum Zitat Persiani R, Biondi A, Pennestri F et al (2018) Transanal total mesorectal excision vs laparoscopic total mesorectal excision in the treatment of low and middle rectal cancer: a propensity score matching analysis. Dis Colon Rectum 61(7):809–816CrossRef Persiani R, Biondi A, Pennestri F et al (2018) Transanal total mesorectal excision vs laparoscopic total mesorectal excision in the treatment of low and middle rectal cancer: a propensity score matching analysis. Dis Colon Rectum 61(7):809–816CrossRef
5.
Zurück zum Zitat Wasmuth HH, Faerden AE, Myklebust TA et al (2020) Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 107(1):121–130CrossRef Wasmuth HH, Faerden AE, Myklebust TA et al (2020) Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 107(1):121–130CrossRef
6.
Zurück zum Zitat European Society of Coloproctology collaborating (2018) An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME). Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 20 Suppl 6:33–46 European Society of Coloproctology collaborating (2018) An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME). Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 20 Suppl 6:33–46
7.
Zurück zum Zitat Lin D, Yu Z, Chen W et al (2019) Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes. Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques 14(3): 353–65 Lin D, Yu Z, Chen W et al (2019) Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes. Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques 14(3): 353–65
8.
Zurück zum Zitat Ren J, Luo H, Liu S, Wang B, Wu F (2021) Short- and mid-term outcomes of transanal versus laparoscopic total mesorectal excision for low rectal cancer: a meta-analysis. Annals of surgical treatment and research 100(2):86–99CrossRef Ren J, Luo H, Liu S, Wang B, Wu F (2021) Short- and mid-term outcomes of transanal versus laparoscopic total mesorectal excision for low rectal cancer: a meta-analysis. Annals of surgical treatment and research 100(2):86–99CrossRef
9.
Zurück zum Zitat Hajibandeh S, Hajibandeh S, Eltair M et al (2020) Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer. Int J Colorectal Dis 35(4):575–593CrossRef Hajibandeh S, Hajibandeh S, Eltair M et al (2020) Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer. Int J Colorectal Dis 35(4):575–593CrossRef
10.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700 Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700
11.
Zurück zum Zitat Bjoern MX, Nielsen S, Perdawood SK (2019) Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches. J Gastrointest Surg 23(8):1623–1630CrossRef Bjoern MX, Nielsen S, Perdawood SK (2019) Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches. J Gastrointest Surg 23(8):1623–1630CrossRef
12.
Zurück zum Zitat Detering R, Roodbeen SX, van Oostendorp SE et al (2019) Three-year nationwide experience with transanal total mesorectal excision for rectal cancer in the netherlands: a propensity score-matched comparison with conventional laparoscopic total mesorectal excision. J Am Coll Surg 228(3):235–44 e1 Detering R, Roodbeen SX, van Oostendorp SE et al (2019) Three-year nationwide experience with transanal total mesorectal excision for rectal cancer in the netherlands: a propensity score-matched comparison with conventional laparoscopic total mesorectal excision. J Am Coll Surg 228(3):235–44 e1
13.
Zurück zum Zitat Sparreboom CL, Komen N, Rizopoulos D et al (2019) Transanal total mesorectal excision: how are we doing so far? Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 21(7):767–774CrossRef Sparreboom CL, Komen N, Rizopoulos D et al (2019) Transanal total mesorectal excision: how are we doing so far? Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 21(7):767–774CrossRef
14.
Zurück zum Zitat Rubinkiewicz M, Zarzycki P, Witowski J et al (2019) Functional outcomes after resections for low rectal tumors: comparison of Transanal with laparoscopic Total Mesorectal excision. BMC Surg 19(1):79CrossRef Rubinkiewicz M, Zarzycki P, Witowski J et al (2019) Functional outcomes after resections for low rectal tumors: comparison of Transanal with laparoscopic Total Mesorectal excision. BMC Surg 19(1):79CrossRef
15.
Zurück zum Zitat Zuhdy M, Elmore U, Shams N et al (2020) Transanal versus laparoscopic total mesorectal excision: a comparative prospective clinical trial from two centers. J Laparoendosc Adv Surg Tech A 30(7):769–776CrossRef Zuhdy M, Elmore U, Shams N et al (2020) Transanal versus laparoscopic total mesorectal excision: a comparative prospective clinical trial from two centers. J Laparoendosc Adv Surg Tech A 30(7):769–776CrossRef
16.
Zurück zum Zitat Ren J, Liu S, Luo H, Wang B, Wu F (2021) Comparison of short-term efficacy of transanal total mesorectal excision and laparoscopic total mesorectal excision in low rectal cancer. Asian J Surg 44(1):181–185CrossRef Ren J, Liu S, Luo H, Wang B, Wu F (2021) Comparison of short-term efficacy of transanal total mesorectal excision and laparoscopic total mesorectal excision in low rectal cancer. Asian J Surg 44(1):181–185CrossRef
17.
Zurück zum Zitat Alhanafy MK, Park SS, Park SC et al (2020) Early experience with transanal total mesorectal excision compared with laparoscopic total mesorectal excision for rectal cancer: a propensity score-matched analysis. Dis Colon Rectum 63(11):1500–1510CrossRef Alhanafy MK, Park SS, Park SC et al (2020) Early experience with transanal total mesorectal excision compared with laparoscopic total mesorectal excision for rectal cancer: a propensity score-matched analysis. Dis Colon Rectum 63(11):1500–1510CrossRef
18.
Zurück zum Zitat Ye J, Tian Y, Li F et al (2021) Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: a case matched study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 47(5):1019–1025CrossRef Ye J, Tian Y, Li F et al (2021) Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: a case matched study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 47(5):1019–1025CrossRef
19.
Zurück zum Zitat Zeng Z, Liu Z, Luo S et al (2021) Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer. Surg Endoscopy Zeng Z, Liu Z, Luo S et al (2021) Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer. Surg Endoscopy
20.
Zurück zum Zitat Chen YT, Kiu KT, Yen MH, Chang TC (2019) Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME. Asian J Surg 42(6):674–680CrossRef Chen YT, Kiu KT, Yen MH, Chang TC (2019) Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME. Asian J Surg 42(6):674–680CrossRef
21.
Zurück zum Zitat Veltcamp Helbach M, Koedam TWA, Knol JJ et al (2019) Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc 33(1):79–87CrossRef Veltcamp Helbach M, Koedam TWA, Knol JJ et al (2019) Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc 33(1):79–87CrossRef
22.
Zurück zum Zitat Perdawood SK, Warnecke M, Bjoern MX, Eiholm S (2019) The pattern of defects in mesorectal specimens: is there a difference between transanal and laparoscopic approaches? Scand J Surg 108(1):49–54CrossRef Perdawood SK, Warnecke M, Bjoern MX, Eiholm S (2019) The pattern of defects in mesorectal specimens: is there a difference between transanal and laparoscopic approaches? Scand J Surg 108(1):49–54CrossRef
23.
Zurück zum Zitat Mege D, Hain E, Lakkis Z, Maggiori L, Prost AlDJ, Panis Y. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 2018; 20(6): O143-O51. Mege D, Hain E, Lakkis Z, Maggiori L, Prost AlDJ, Panis Y. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 2018; 20(6): O143-O51.
24.
Zurück zum Zitat Chang TC, Kiu KT (2018) Transanal total mesorectal excision in lower rectal cancer: comparison of short-term outcomes with conventional laparoscopic total mesorectal excision. J Laparoendosc Adv Surg Tech A 28(4):365–369CrossRef Chang TC, Kiu KT (2018) Transanal total mesorectal excision in lower rectal cancer: comparison of short-term outcomes with conventional laparoscopic total mesorectal excision. J Laparoendosc Adv Surg Tech A 28(4):365–369CrossRef
25.
Zurück zum Zitat Lelong B, Meillat H, Zemmour C et al (2017) Short- and mid-term outcomes after endoscopic transanal or laparoscopic transabdominal total mesorectal excision for low rectal cancer: a single institutional case-control study. J Am Coll Surg 224(5):917–925CrossRef Lelong B, Meillat H, Zemmour C et al (2017) Short- and mid-term outcomes after endoscopic transanal or laparoscopic transabdominal total mesorectal excision for low rectal cancer: a single institutional case-control study. J Am Coll Surg 224(5):917–925CrossRef
26.
Zurück zum Zitat Chouillard E, Regnier A, Vitte RL et al (2016) Transanal NOTES total mesorectalexcision (TME) in patients with rectal cancer: is anatomy better preserved? Tech Coloproctol 20(8):537–544CrossRef Chouillard E, Regnier A, Vitte RL et al (2016) Transanal NOTES total mesorectalexcision (TME) in patients with rectal cancer: is anatomy better preserved? Tech Coloproctol 20(8):537–544CrossRef
27.
Zurück zum Zitat Rasulov AO, Mamedli ZZ, Gordeyev SS, Kozlov NA, Dzhumabaev HE (2016) Short-term outcomes after transanal and laparoscopic total esorectal excision for rectal cancer. Tech Coloproctol 20(4):227–234CrossRef Rasulov AO, Mamedli ZZ, Gordeyev SS, Kozlov NA, Dzhumabaev HE (2016) Short-term outcomes after transanal and laparoscopic total esorectal excision for rectal cancer. Tech Coloproctol 20(4):227–234CrossRef
28.
Zurück zum Zitat Chen CC, Lai YL, Jiang JK et al (2016) Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study. Ann Surg Oncol 23(4):1169–1176CrossRef Chen CC, Lai YL, Jiang JK et al (2016) Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study. Ann Surg Oncol 23(4):1169–1176CrossRef
29.
Zurück zum Zitat de'Angelis N, Portigliotti L, Azoulay D, Brunetti F (2015) Transanal total mesorectal excision for rectal cancer: a single center experience and systematic review of theliterature. Langenbecks Arch Surg 400(8):945–59. de'Angelis N, Portigliotti L, Azoulay D, Brunetti F (2015) Transanal total mesorectal excision for rectal cancer: a single center experience and systematic review of theliterature. Langenbecks Arch Surg 400(8):945–59.
30.
Zurück zum Zitat Kanso F, Maggiori L, Debove C, Chau A, Ferron M, Panis Y (2015) Perineal or abdominal approach first during intersphincteric resection for low rectal cancer: which is the best strategy? Dis Colon Rectum 58(7):637–644CrossRef Kanso F, Maggiori L, Debove C, Chau A, Ferron M, Panis Y (2015) Perineal or abdominal approach first during intersphincteric resection for low rectal cancer: which is the best strategy? Dis Colon Rectum 58(7):637–644CrossRef
31.
Zurück zum Zitat Fernandez-Hevia M, Delgado S, Castells A et al (2015) Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Surg 261(2):221–227CrossRef Fernandez-Hevia M, Delgado S, Castells A et al (2015) Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Surg 261(2):221–227CrossRef
32.
Zurück zum Zitat Velthuis S, Nieuwenhuis DH, Ruijter TE, Cuesta MA, Bonjer HJ, Sietses C (2014) Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma. Surg Endosc 28(12):3494–3499CrossRef Velthuis S, Nieuwenhuis DH, Ruijter TE, Cuesta MA, Bonjer HJ, Sietses C (2014) Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma. Surg Endosc 28(12):3494–3499CrossRef
33.
Zurück zum Zitat Denost Q, Adam JP, Rullier A, Buscail E, Laurent C, Rullier E (2014) Perineal transanal approach: a new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial. Ann Surg 260(6):993–999CrossRef Denost Q, Adam JP, Rullier A, Buscail E, Laurent C, Rullier E (2014) Perineal transanal approach: a new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial. Ann Surg 260(6):993–999CrossRef
34.
Zurück zum Zitat Wu A, He G, Wang L et al (2018) Short-term outcome of transanal total mesorectal excision for male low rectal cancer patients with “difficult pelvis”: a single center report from Peking University Cancer Hospital. Zhonghua Wei Chang Wai Ke Za Zhi 21(6):646–653PubMed Wu A, He G, Wang L et al (2018) Short-term outcome of transanal total mesorectal excision for male low rectal cancer patients with “difficult pelvis”: a single center report from Peking University Cancer Hospital. Zhonghua Wei Chang Wai Ke Za Zhi 21(6):646–653PubMed
35.
Zurück zum Zitat Marks G, Mohiuddin M, Rakinic J (1991) New hope and promise for sphincter preservation in the management of cancer of the rectum. Semin Oncol 18(4):388–98 Marks G, Mohiuddin M, Rakinic J (1991) New hope and promise for sphincter preservation in the management of cancer of the rectum. Semin Oncol 18(4):388–98
36.
Zurück zum Zitat Birbeck KF, Macklin CP, Tiffin NJ et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235(4):449–457CrossRef Birbeck KF, Macklin CP, Tiffin NJ et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235(4):449–457CrossRef
37.
Zurück zum Zitat Aubert M, Mege D, Panis Y (2020) Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis. Surg Endosc 34(9):3908–3919CrossRef Aubert M, Mege D, Panis Y (2020) Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis. Surg Endosc 34(9):3908–3919CrossRef
38.
Zurück zum Zitat Vignali A, Elmore U, Milone M, Rosati R (2019) Transanal total mesorectal excision (TaTME): current status and future perspectives. Updates Surg 71(1):29–37CrossRef Vignali A, Elmore U, Milone M, Rosati R (2019) Transanal total mesorectal excision (TaTME): current status and future perspectives. Updates Surg 71(1):29–37CrossRef
39.
Zurück zum Zitat Marr R, Birbeck K, Garvican J et al (2005) The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 242(1):74–82CrossRef Marr R, Birbeck K, Garvican J et al (2005) The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 242(1):74–82CrossRef
40.
Zurück zum Zitat Nagtegaal ID, van de Velde CJ, Marijnen CA et al (2005) Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23(36):9257–9264CrossRef Nagtegaal ID, van de Velde CJ, Marijnen CA et al (2005) Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23(36):9257–9264CrossRef
41.
Zurück zum Zitat van der Pas MH, Haglind E, Cuesta MA et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218CrossRef van der Pas MH, Haglind E, Cuesta MA et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218CrossRef
42.
Zurück zum Zitat Veltcamp Helbach M, Deijen CL, Velthuis S, Bonjer HJ, Tuynman JB, Sietses C (2016) Transanal total mesorectal excision for rectal carcinoma: short-term outcomes and experience after 80 cases. Surg Endosc 30(2):464–470CrossRef Veltcamp Helbach M, Deijen CL, Velthuis S, Bonjer HJ, Tuynman JB, Sietses C (2016) Transanal total mesorectal excision for rectal carcinoma: short-term outcomes and experience after 80 cases. Surg Endosc 30(2):464–470CrossRef
43.
Zurück zum Zitat Lacy AM, Tasende MM, Delgado S et al (2015) Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 221(2):415–423CrossRef Lacy AM, Tasende MM, Delgado S et al (2015) Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 221(2):415–423CrossRef
44.
Zurück zum Zitat Burke JP, Martin-Perez B, Khan A et al (2016) Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 18(6):570–577CrossRef Burke JP, Martin-Perez B, Khan A et al (2016) Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 18(6):570–577CrossRef
45.
Zurück zum Zitat Kwon SH, Joo YI, Kim SH et al (2021) Meta-analysis of transanal versus laparoscopic total mesorectal excision for rectal cancer: a “New Health Technology” assessment in South Korea. Annals of surgical treatment and research 101(3):167–180CrossRef Kwon SH, Joo YI, Kim SH et al (2021) Meta-analysis of transanal versus laparoscopic total mesorectal excision for rectal cancer: a “New Health Technology” assessment in South Korea. Annals of surgical treatment and research 101(3):167–180CrossRef
Metadaten
Titel
Pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of 26 studies
Publikationsdatum
11.04.2022
Erschienen in
International Journal of Colorectal Disease / Ausgabe 5/2022
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-022-04147-1

Weitere Artikel der Ausgabe 5/2022

International Journal of Colorectal Disease 5/2022 Zur Ausgabe

Ist die Spülung bei Bohrlochtrepanation verzichtbar?

19.06.2024 Subduralhämatom Nachrichten

Wird ein chronisches Subduralhämatom per Bohrlochtrepanation entfernt, scheint eine subdurale Ausspülung mehr Vor- als Nachteile zu haben. Das legen Ergebnisse einer finnischen Studie nahe.

Was eine zu kleine Klappe für die Langzeitprognose bedeutet

18.06.2024 Aortenklappenersatz Nachrichten

Stellt sich nach der Implantation eines biologischen Aortenklappenersatzes die Prothese als zu klein für den Patienten heraus, hat das offenbar nur geringe Auswirkungen auf Langzeitüberleben und Reoperationsrisiko; zumindest solange die effektive Öffnungsfläche über 0,65 cm2/m2 liegt.

Antibiotika nach Appendektomie: Ist kürzer besser?

18.06.2024 Appendizitis Nachrichten

Nach einer Appendektomie wegen komplizierter Appendizitis scheint eine maximal dreitägige Antibiotikabehandlung hinreichend vor Komplikationen wie intraabdominellen Abszessen und Wundinfektionen zu schützen.

TAVI bei kleinem Aortenklappenanulus: Es gibt noch ungeklärte Fragen

13.06.2024 TAVI Nachrichten

Zwischen selbstexpandierenden und ballonexpandierbaren TAVI-Klappen scheinen bezüglich der Klappenfunktion bei Aortenstenose und kleinem Aortenklappenanulus Unterschiede zu bestehen. Aber sind die überhaupt von klinischer Relevanz? Eine neue Studie liefert dazu Informationen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.